(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011 at 7:30 a.m. PT (10:30 a.m. ET) at The Westin St. Francis in San Francisco. This presentation will include a review of the company’s 2010 goals and the key scientific, product, and business goals for 2011.
